Bitte verwenden Sie diesen Link, um diese Publikation zu zitieren, oder auf sie als Internetquelle zu verweisen: https://hdl.handle.net/10419/278513 
Autor:innen: 
Erscheinungsjahr: 
2023
Schriftenreihe/Nr.: 
Research Paper No. 178
Verlag: 
South Centre, Geneva
Zusammenfassung: 
The unequal global distribution of vaccines against the deadly COVID-19 virus has cast a spotlight on the lack of access to vaccines on the African continent, and the vulnerability that such a lack places on both the economies of African nations and the health of their people. Various initiatives have been launched to overcome the dependence of African nations on vaccines produced elsewhere. If implemented in timely and effective ways, those initiatives will contribute to the diversification of African economies and strengthen the capacity of nations on the continent to address their public health needs during pandemics and at other times. While establishing a viable vaccine industry on the continent presents serious challenges, the African Continental Free Trade Area (AfCFTA) can provide the framework for leveraging economies of scale to stimulate the production of needed vaccines across the region.
Schlagwörter: 
Access to Medicines
Access to Vaccines
Africa
African Continental Free Trade Area (AfCFTA)
African Union (AU)
COVID-19
Global Health
Health
Intellectual Property
Pandemic
Public Health
Vaccine Equity
Vaccine Industry
Vaccine Inequity
Vaccine Nationalism
Vaccine Production
Vaccines
Dokumentart: 
Research Report
Erscheint in der Sammlung:

Datei(en):
Datei
Größe
4.94 MB





Publikationen in EconStor sind urheberrechtlich geschützt.